Inhibition Mechanisms of Protein Disulfide Isomerase on α-Synuclein Fibril Aggregation

doi:10.11938/cjmr20170201

Abstract

Abstract: Abnormal aggregation of α-synuclein, an intrinsically disordered protein in Lewy bodies, is considered a hallmark of Parkinson's disease (PD). The mechanisms underlying abnormal α-synuclein aggregation, however, are yet to be understood. Protein disulfide isomerase (PDI) is an important molecular chaperone in the endoplasmic reticulum, which can prevent disordered protein forming aggregation. PDI is shown to be overexpressed in the brain of PD patients, but with reduced activity due to S-nitrosylation of the cysteine residues in the active site. In vitro experiments have demonstrated that PDI can inhibit the aggregation of α-synuclein with unknown mechanisms. Hence, it may be of importance to study the inhibition mechanisms of PDI on α-synuclein aggregation. In this study, the interaction between α-synuclein and PDI was studied by NMR spectroscopy. It was found that the binding sites between the two are located on the N-terminal of α-synuclein. A variant PDI (PDI C-S) was prepared, in which all six cysteines were mutated to serines. It was found that the binding sites between PDI C-S and α-synuclein are located on the C-terminus of α-synuclein. The results of thioflavin T (ThT) fluorescence experiment showed that the inhibition activity of PDI C-S on α-synuclein aggregation was lower than the wild type, suggesting that wild type PDI may inhibit α-synuclein aggregation through binding to its N-terminal.

Key words: interaction, protein disulfide isomerase (PDI), NMR, α-synuclein

CLC Number:

O482.53

CHEN Yan-hua, ZHANG Ze-ting, BAI Jia, LIU Xiao-li, LIU Mai-li, LI Cong-gang. Inhibition Mechanisms of Protein Disulfide Isomerase on α-Synuclein Fibril Aggregation[J]. Chinese Journal of Magnetic Resonance, 2017, 34(2): 131-136.

References

[1] SPILLANTINI M G, CROWTHER R A, JAKES R, et al. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies[J]. P Natl Acad Sci USA, 1998, 95(11):6469-6473.
[2] KESSLER J C, ROCHET J C, LANSBURY P T. The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation[J]. Biochemistry, 2003, 42(3):672-678.
[3] ELIEZER D, KUTLUAY E, BUSSELL R, et al. Conformational properties of alpha-synuclein in its free and lipid-associated states[J]. J Mol Biol, 2001, 307(4):1061-1073.
[4] UVERSKY V N, FINK A. Amino acid determinants of alpha-synuclein aggregation:putting together pieces of the puzzle[J]. Febs Lett, 2002, 522(1-3):9-13.
[5] ZHANG L, ZHANG C Y, ZHU Y Y, et al. Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons:An immunogold electron microscopic study using a C-terminal specific monoclonal antibody[J]. Brain Res, 2008, 1244:40-52.
[6] SMITH W W, JIANG H B, PEI Z, et al. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity[J]. Hum Mol Genet, 2005, 14(24):3801-3811.
[7] LYLES M M, GILBERT H F. Catalysis of the oxidative folding of ribonuclease-a by protein disulfide isomerase-dependence of the rate on the composition of the redox buffer[J]. Biochemistry, 1991, 30(3):613-619.
[8] FREEDMAN R B, DUNN A D, RUDDOCK L W. Protein folding:A missing redox link in the endoplasmic reticulum[J]. Curr Biol, 1998, 8(13):468-470.
[9] CAI H, WANG C C, TSOU C L. Chaperone-like activity of protein disulfide-isomerase in the refolding of a protein with no disulfide bonds[J]. J Biol Chem, 1994, 269(40):24550-24552.
[10] MAATTANEN P, GEHRING K, BERGERON J J M, et al. Protein quality control in the ER:The recognition of misfolded proteins[J]. Semin Cell Dev Biol, 2010, 21(5):500-511.
[11] WANG C, LI W, REN J Q, et al. Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase[J]. Antioxid Redox Sign, 2013, 19(1):44-53.
[12] KLAPPA P, RUDDOCK L W, DARBY N J, et al. The b' domain provides the principal peptide-binding site of protein disulfide isomerase but all domains contribute to binding of misfolded proteins[J]. Embo J, 1998, 17(4):927-935.
[13] FREEDMAN R B, GANE P J, HAWKINS H C, et al. Experimental and theoretical analyses of the domain architecture of mammalian protein disulphide-isomerase[J]. Biol Chem, 1998, 379(3):321-328.
[14] UEHARA T, NAKAMURA T, YAO D D, et al. S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration[J]. Nature, 2006, 441(7092):513-517.
[15] NAKAMURA T, TU S C, AKHTAR M W, et al. Aberrant protein S-nitrosylation in neurodegenerative diseases[J]. Neuron, 2013, 78(4):596-614.
[16] CHENG H, WANG L, WANG C C. Domain a' of protein disulfide isomerase plays key role in inhibiting alpha-synuclein fibril formation[J]. Cell Stress Chaperon, 2010, 15(4):415-421.
[17] DAI C Y, ZHANG Z T, LIU M L, et al. Application of NMR in the studies of structure and interactions of α-synuclein[J]. Chinese J Magn Reson, 2016, 33(1):154-167. 戴晨晔, 张则婷, 刘买利, 等. NMR在α-synuclein的结构及相互作用研究中的应用[J]. 波谱学杂志, 2016, 33(1):154-167.
[18] KHURANA R, COLEMAN C, IONESCU-ZANETTI C, et al. Mechanism of thioflavin T binding to amyloid fibrils[J]. J Struct Biol, 2005, 151(3):229-238.
[19] DAI C Y, LIU M L, LI C G. Salt content-dependent conformational changes of α-synuclein studied by ¹⁹F NMR[J]. Chinese J Magn Reson, 2015, 32(1):33-40. 戴晨晔, 刘买利, 李从刚. 低盐和高盐环境下α-synuclein构象的¹⁹F NMR研究[J]. 波谱学杂志, 2015, 32(1):33-40.
[20] RAO J N, DUA V, ULMER T S. Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules[J]. Biochemistry, 2008, 47(16):4651-4656.
[21] XIE Y Y, ZHOU C J, ZHOU Z R, et al. Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein:mechanistic insights and pathological implication[J]. Faseb J, 2010, 24(1):196-205.
[22] ZABROCKI P, BASTIAENS I, DELAY C, et al. Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson[J]. BBA-Mol Cell Res, 2008, 1783(10):1767-1780.
[23] YU J P, MALKOVA S, LYUBCHENKO Y L. Alpha-synuclein misfolding:Single molecule AFM force spectroscopy study[J]. J Mol Biol, 2008, 384(4):992-1001.
[24] HONG D P, XIONG W, CHANG J Y, et al. The role of the C-terminus of human alpha-synuclein:Intra-disulfide bonds between the C-terminus and other regions stabilize non-fibrillar monomeric isomers[J]. Febs Lett, 2011, 585(3):561-566.
[25] LOWE R, POUNTNEY D L, JENSEN P H, et al. Calcium(Ⅱ) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain[J]. Protein Sci, 2004, 13(12):3245-3252.
[26] LI W X, WEST N, COLLA E, et al. Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations[J]. P Natl Acad Sci USA, 2005, 102(6):2162-2167.